This study is exploring a new treatment called **SCONE neuromodulation therapy** for people with **Neurogenic Lower Urinary Tract Dysfunction (NLUTD)**. This condition affects how the bladder works due to problems with the nerves. The treatment will be tested over a period of 12 weeks and compared to a fake (inactive) treatment to see if it helps improve symptoms safely.

• The study lasts for 12 weeks and involves therapy sessions.
• Participants must be between 18 and 75 years old and meet specific health criteria.
• Participants cannot have certain medical conditions or rely on certain medical devices.

To join, participants need to be diagnosed with NLUTD caused by spinal cord injury, multiple sclerosis, or stroke. They must also have specific bladder symptoms, like frequent urges to urinate or leakage. Certain health conditions or devices, like heart failure or a pacemaker, will exclude someone from joining. Participants will need to attend sessions and follow study rules. If you're interested, make sure you meet the criteria and are willing to commit to the study requirements.